Scared Of on MSN
Phobias that quietly shape daily decisions
You've probably made a dozen choices today without questioning why. Which route you took to work, whether you attended that ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Morning Overview on MSN
Researchers think they’ve found a path to restoring human vision
For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback